Department of the Army, US Army Medical Research Acquisition Activity: Center of Excellence for Individualization of Therapy for Breast Cancer: Predicting Response and Toxicity in Patients Receiving Paclitaxel and Avastin for Breast Cancer: A Multicenter Genomic, Proteomic and Pharmacogenomic Correlative Study